{"entity":{"id":"idea-fund-cross-funder-portfolio-registry","kind":"idea","name":"Mandatory machine-readable portfolio reporting for all large cancer funders","aka":[],"tldr":"Every funder that spends more than $50 million a year on cancer research would publish what it funds in a shared, coded database, so gaps and duplication can be seen across the whole system.","summary":"The International Cancer Research Partnership already codes members' portfolios by cancer type and Common Scientific Outline category, but participation is voluntary and misses most industry-funded academic work, Chinese funders and a large part of European funding. Governments and umbrella bodies would require reporting as a condition of charitable tax status or public co-funding, with a common ontology, award-level data and outputs linked (publications, trials, patents). Coverage is what turns a nice database into a planning tool.","asOf":"2026-09-08","links":[{"label":"International Cancer Research Partnership","url":"https://www.icrpartnership.org/"}],"tags":[],"related":["idea-fund-burden-weighted-portfolio","idea-fund-dollars-per-death-dashboard"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["cruk","nci","dkfz"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-funding-allocation","b-data-silos"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Raising portfolio-registry coverage above 80% of global non-industry cancer research spend enables at least three documented cases per year where funders reallocate or co-fund to fill identified gaps or eliminate duplication.","rationale":"Coded portfolio analysis has already exposed funding imbalances in the UK and US; the missing piece is coverage and enforcement. Clinical trial registration went from voluntary and patchy to near-universal once journals and regulators made it mandatory.","test":"One country mandates reporting for two years; measure coverage, the number of gap analyses produced and documented reallocation decisions citing the registry.","maturity":"speculative","actor":"data","cost":"small","horizonYears":2},"route":"/ideas/idea-fund-cross-funder-portfolio-registry/","neighbours":{"idea":[{"id":"idea-fund-dollars-per-death-dashboard","kind":"idea","name":"A public dashboard of research money per death for every cancer","route":"/ideas/idea-fund-dollars-per-death-dashboard/"},{"id":"idea-fund-burden-weighted-portfolio","kind":"idea","name":"Burden-weighted portfolio targets for every major cancer funder","route":"/ideas/idea-fund-burden-weighted-portfolio/"}],"institution":[{"id":"cruk","kind":"institution","name":"Cancer Research UK","route":"/institutions/cruk/"},{"id":"dkfz","kind":"institution","name":"German Cancer Research Center (DKFZ)","route":"/institutions/dkfz/"},{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"}],"bottleneck":[{"id":"b-data-silos","kind":"bottleneck","name":"Data silos","route":"/bottlenecks/b-data-silos/"},{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"}]}}